Screener
Design Therapeutics, Inc. DSGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $656.19M.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026. Open the filing →
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
FAQ
- What is Design Therapeutics, Inc.'s market capitalization?
- Design Therapeutics, Inc. (DSGN) reported market capitalization of $656.19M in Q1 2026.
- How has Design Therapeutics, Inc.'s market capitalization changed year-over-year?
- Design Therapeutics, Inc.'s market capitalization increased by 199.5% year-over-year, from $219.1M to $656.19M.
- What is the long-term trend for Design Therapeutics, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s market capitalization has grown at a -18.1% compound annual growth rate (CAGR), from $1.19B to $534.32M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Design Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude